Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.

Byerly MJ, Marcus RN, Tran QV, Eudicone JM, Whitehead R, Baker RA.

Schizophr Res. 2009 Feb;107(2-3):218-22. doi: 10.1016/j.schres.2008.09.019. Epub 2008 Nov 26.

PMID:
19038534
2.

Initiation of aripiprazole once-monthly in patients with schizophrenia.

Raoufinia A, Baker RA, Eramo A, Nylander AG, Landsberg W, Kostic D, Larsen F.

Curr Med Res Opin. 2015 Mar;31(3):583-92. doi: 10.1185/03007995.2015.1006356. Epub 2015 Feb 5. Review.

PMID:
25586294
3.

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.

Swainston Harrison T, Perry CM.

Drugs. 2004;64(15):1715-36. Review.

PMID:
15257633
4.

Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.

Almandil NB, Liu Y, Murray ML, Besag FM, Aitchison KJ, Wong IC.

Paediatr Drugs. 2013 Apr;15(2):139-50. doi: 10.1007/s40272-013-0016-6. Review.

PMID:
23519708
5.

A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.

Gao K, Ganocy SJ, Gajwani P, Muzina DJ, Kemp DE, Calabrese JR.

J Clin Psychiatry. 2008 Feb;69(2):302-9. Review.

PMID:
18211129
6.

Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.

Wisniewski CS, Robert S.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1097-104. doi: 10.1345/aph.1Q700. Epub 2012 Jul 17. Review.

PMID:
22811346
7.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
8.

Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review.

Cañas F, Möller HJ.

Expert Opin Drug Saf. 2010 Sep;9(5):683-97. doi: 10.1517/14740338.2010.506712. Review. Erratum in: Expert Opin Drug Saf. 2010 Nov;9(6):1007.

PMID:
20690885
9.

Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.

Wen XJ, Wang LM, Liu ZL, Huang A, Liu YY, Hu JY.

Braz J Med Biol Res. 2014 Jul;47(7):605-16. Epub 2014 Jun 13. Review.

10.

The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Peuskens J, Pani L, Detraux J, De Hert M.

CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3. Review.

11.

Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.

Ennis ZN, Damkier P.

Basic Clin Pharmacol Toxicol. 2015 Apr;116(4):315-20. doi: 10.1111/bcpt.12372. Epub 2015 Jan 28. Review.

12.

Switching and combining antipsychotics.

Correll CU.

CNS Spectr. 2010 Apr;15(4 Suppl 6):8-11. Review. No abstract available.

PMID:
21141654
13.

Antipsychotic switching in schizoaffective disorder: A systematic review.

Murru A, Hidalgo D, Bernardo M, Bobes J, Saiz-Ruiz J, Álamo C, Vieta E.

World J Biol Psychiatry. 2016 Oct;17(7):495-513. doi: 10.3109/15622975.2015.1012225. Epub 2015 Mar 9. Review.

PMID:
25751661
14.

Hypothermia and rhabdomyolysis following olanzapine injection in an adolescent with schizophreniform disorder.

Hung CF, Huang TY, Lin PY.

Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):376-8. doi: 10.1016/j.genhosppsych.2008.09.009. Epub 2008 Oct 18. Review.

PMID:
19555799
15.

Olanzapine long-acting injection: a review of its use in the treatment of schizophrenia.

Frampton JE.

Drugs. 2010 Dec 3;70(17):2289-313. doi: 10.2165/11204930-000000000-00000. Review.

PMID:
21080745
16.

Prolactin serum concentrations during aripiprazole treatment in youth.

Safer DJ, Calarge CA, Safer AM.

J Child Adolesc Psychopharmacol. 2013 May;23(4):282-9. doi: 10.1089/cap.2012.0062. Epub 2013 May 6. Review.

17.

Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.

De Hert M, Detraux J, Stubbs B.

Expert Opin Drug Saf. 2016 Jun;15(6):809-23. doi: 10.1517/14740338.2016.1167873. Epub 2016 Apr 6. Review.

PMID:
26986209
18.

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.

De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, Wildiers H, Detraux J.

Acta Psychiatr Scand. 2016 Jan;133(1):5-22. doi: 10.1111/acps.12459. Epub 2015 Jun 26. Review.

PMID:
26114737
19.

Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management.

Luedecke D, Schöttle D, Karow A, Lambert M, Naber D.

CNS Drugs. 2015 Jan;29(1):41-6. doi: 10.1007/s40263-014-0216-9. Review.

PMID:
25424243
20.

Management of marked liver enzyme increase during olanzapine treatment: a case report and review of the literature.

Manceaux P, Constant E, Zdanowicz N, Jacques D, Reynaert C.

Psychiatr Danub. 2011 Sep;23 Suppl 1:S15-7. Review.

PMID:
21894094

Supplemental Content

Support Center